# Effect of Chronic Supplementation of L-arginine in the Muscular Performance

> **NCT00785811** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 36 (actual)

## Conditions studied

- Muscular Fatigue

## Interventions

- **DRUG:** L-arginine aspartate (Targifor)
- **DRUG:** Placebo L-arginine aspartate (Targifor)

## Key facts

- **NCT ID:** NCT00785811
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Required by the investigator. The site could not recruit patients anymore.
- **Last updated:** 2011-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785811, "Effect of Chronic Supplementation of L-arginine in the Muscular Performance". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00785811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*